000 01654 a2200445 4500
005 20250514161611.0
264 0 _c20031202
008 200312s 0 0 eng d
022 _a0262-0898
024 7 _a10.1023/a:1025860214891
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBratland, Ase
245 0 0 _aThe metalloproteinase inhibitor TIMP-2 is down-regulated by androgens in LNCaP prostate carcinoma cells.
_h[electronic resource]
260 _bClinical & experimental metastasis
_c2003
300 _a541-7 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAndrogens
_xpharmacology
650 0 4 _aCoculture Techniques
650 0 4 _aEnzyme-Linked Immunosorbent Assay
650 0 4 _aGelatin
_xmetabolism
650 0 4 _aGene Expression Regulation, Neoplastic
_xdrug effects
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMatrix Metalloproteinase 2
_xmetabolism
650 0 4 _aMetribolone
_xpharmacology
650 0 4 _aProstatic Neoplasms
_xgenetics
650 0 4 _aRNA, Messenger
_xgenetics
650 0 4 _aTestosterone Congeners
_xpharmacology
650 0 4 _aTissue Inhibitor of Metalloproteinase-2
_xgenetics
650 0 4 _aTumor Cells, Cultured
700 1 _aRagnhildstveit, Erlend
700 1 _aBjørnland, Kristin
700 1 _aAndersen, Kristin
700 1 _aMaelandsmo, Gunhild Mari
700 1 _aFodstad, Oystein
700 1 _aSaatcioglu, Fahri
700 1 _aRee, Anne Hansen
773 0 _tClinical & experimental metastasis
_gvol. 20
_gno. 6
_gp. 541-7
856 4 0 _uhttps://doi.org/10.1023/a:1025860214891
_zAvailable from publisher's website
999 _c14336814
_d14336814